Sanofi-Aventis acquires Genzyme
The CVR entitles Sanofi-aventis to receive additional cash payments if specified milestones related to Lemtrada (alemtuzumab MS) are achieved over time or a milestone related to production volumes
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.
The latest TEKLYNX innovation enables auditable tracking of user activity across TEKLYNX’ proven label design, printing, security and tracing applications. In addition to security measures, TEKLYNX CENTRAL CFR
The products include Kang Xi Eye Patch, KangXi Dental Ulcer Membrane, KangXi Anti-virus Mouthwash, KangXi Dental Ulcer Mouthwash, KangXi Snore Stopper, Kang Xi Periarthritis Shoulder Patch, KangXi Cervical